Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Correlations between HIV-1 clades and HIV-1 antibody neutralization sensitivity: significant for vaccine development?

Current HIV research - 1 Dec 2010

van Gils Marit J, Schuitemaker Hanneke

Abstract excerpt

The correlates of protection against HIV-1 infection or disease progression are still unknown which causes an immense challenge for HIV-1 vaccine design. Existing effective vaccines against other viruses generate antibodies that either block the initial infection or contribute to the eradication...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to Antibodies, Neutralizing
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Antibodies

Share to HIV Infections

Share to Immunity, Humoral

Share to Neutralization Tests

Source

Identifiers

PMID: 21054254
DOI: 10.2174/157016210794088254

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21054254-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Correlations between HIV-1 clades and HIV-1 antibody neutralization sensitivity: significant for vaccine development?PMID 21054254Read ↗

Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune ResponseSemantic proximity Read ↗

Harnessing the protective potential of HIV-1 neutralizing antibodiesSemantic proximity Read ↗

Catch Me If You Can--The Race Between HIV and Neutralizing Antibodies.Semantic proximity Read ↗

Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.Semantic proximity Read ↗

Virological features associated with the development of broadly neutralizing antibodies to HIV-1.Semantic proximity Read ↗

Identification of neutralising determinants in protection against HIV-1Semantic proximity Read ↗

Cross‐Reactivity of Anti–HIV‐1 T Cell Immune Responses among the Major HIV‐1 Clades in HIV‐1–Positive Individuals from 4 ContinentsSemantic proximity Read ↗

Broadly neutralizing antibodies against HIV-1: Templates for a vaccineSemantic proximity Read ↗

Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.Semantic proximity Read ↗

HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.Semantic proximity Read ↗

A critical question for HIV vaccine development: which antibodies to induce?Semantic proximity Read ↗

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.